ACCRETAMAB Trademark

Trademark Overview


On Wednesday, May 27, 2015, a trademark application was filed for ACCRETAMAB with the United States Patent and Trademark Office. The USPTO has given the ACCRETAMAB trademark a serial number of 86643143. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 20, 2022. This trademark is owned by Kyowa Hakko Kirin Co., Ltd.. The ACCRETAMAB trademark is filed in the Pharmaceutical Products category with the following description:

Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contracepti...
accretamab

General Information


Serial Number86643143
Word MarkACCRETAMAB
Filing DateWednesday, May 27, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 20, 2022
Registration Number4851400
Registration DateTuesday, November 10, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements


Goods and ServicesHost cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKYOWA KIRIN CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTOKYO
JP

Party NameKyowa Hakko Kirin Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Party NameKyowa Hakko Kirin Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo
JP

Party NameKyowa Hakko Kirin Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Trademark Events


Event DateEvent Description
Friday, May 20, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, November 10, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 4, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 10, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 25, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 20, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 13, 2015ASSIGNED TO LIE
Wednesday, July 1, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 16, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 16, 2015NON-FINAL ACTION E-MAILED
Tuesday, June 16, 2015NON-FINAL ACTION WRITTEN
Saturday, June 13, 2015ASSIGNED TO EXAMINER
Wednesday, June 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 30, 2015NEW APPLICATION ENTERED IN TRAM